Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Andersen

Showing results (511-520 of 530) with videos related to

Pageof 53
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2019
Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tubeElisa Nemes, Deborah Abrahams, Thomas J Scriba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALDEllen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
The Lancet. Gastroenterology & Hepatology|June 2, 2026
Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort studyJesse Pustjens, Katrine Tholstrup Bech, Guillem Pera, et al.
Annals of Internal Medicine|December 12, 2022
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled TrialCamilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
Gastroenterology|February 27, 2023
Sphingolipids Are Depleted in Alcohol-Related Liver FibrosisMaja Thiele, Tommi Suvitaival, Kajetan Trošt, et al.
The New England Journal of Medicine|July 12, 2018
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG RevaccinationElisa Nemes, Hennie Geldenhuys, Virginie Rozot, et al.
Science Translational Medicine|February 18, 2021
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathyStephen P Chelko, Gizem Keceli, Andrea Carpi, et al.
Vaccine|June 23, 2015
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adultsAngelique Kany Kany Luabeya, Benjamin M N Kagina, Michele D Tameris, et al.
Journal of Clinical Microbiology|July 29, 2020
Diagnostic Accuracy of Interferon Gamma-Induced Protein 10 mRNA Release Assay for TuberculosisThomas Blauenfeldt, Raquel Villar-Hernández, Esther García-García, et al.
The Lancet. Respiratory Medicine|February 5, 2017
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trialMorten Ruhwald, Henrik Aggerbeck, Rafael Vázquez Gallardo, et al.
Pageof 53

Showing results (511-520 of 530) with videos related to

Sort By:
Pageof 53
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2019
Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tubeElisa Nemes, Deborah Abrahams, Thomas J Scriba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALDEllen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
The Lancet. Gastroenterology & Hepatology|June 2, 2026
Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort studyJesse Pustjens, Katrine Tholstrup Bech, Guillem Pera, et al.
Annals of Internal Medicine|December 12, 2022
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled TrialCamilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
Gastroenterology|February 27, 2023
Sphingolipids Are Depleted in Alcohol-Related Liver FibrosisMaja Thiele, Tommi Suvitaival, Kajetan Trošt, et al.
The New England Journal of Medicine|July 12, 2018
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG RevaccinationElisa Nemes, Hennie Geldenhuys, Virginie Rozot, et al.
Science Translational Medicine|February 18, 2021
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathyStephen P Chelko, Gizem Keceli, Andrea Carpi, et al.
Vaccine|June 23, 2015
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adultsAngelique Kany Kany Luabeya, Benjamin M N Kagina, Michele D Tameris, et al.
Journal of Clinical Microbiology|July 29, 2020
Diagnostic Accuracy of Interferon Gamma-Induced Protein 10 mRNA Release Assay for TuberculosisThomas Blauenfeldt, Raquel Villar-Hernández, Esther García-García, et al.
The Lancet. Respiratory Medicine|February 5, 2017
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trialMorten Ruhwald, Henrik Aggerbeck, Rafael Vázquez Gallardo, et al.
Pageof 53